The domestically created E-beam technology can enable India to become a worldwide leader in the sterilization of medical devices and various radiation-related applications. India reached a significant milestone when the electron beam (E-beam)...
The expanding pipeline of small molecule medications, their rising intricacy, and the requirement for specialized knowledge are fueling the demand for pharmaceutical contract manufacturing in the fill-finish sector. Moreover, with a greater focus...
The global increase in investment, consequently fueling a significant recovery in developed markets, is observed as a vital market driver for the pharmaceutical-grade synthetic camphor market. Nonetheless, the change in positive market sentiments...
Biocon Biologics, a branch of Biocon, has gained access to the market for the biosimilar Ustekinumab in Europe, the United Kingdom (UK), Canada, and Japan. Ustekinumab is a human monoclonal antibody that inhibits the irregular regulation of...
In the first half of the current fiscal year, imports of surgical products and equipment reached $621.59 million, an increase from the $557.68 million recorded in the same period last fiscal year. Imports increased by 13.03 percent in terms of...
The increase in chronic illnesses is anticipated to drive the need for specialty generic products. There is expected to be a significant increase in the size of the specialty generics market in the coming years. The amount is projected to reach...
India's medical technology sector is projected to reach exports worth USD 20 billion by 2030. The industry body CII mentioned that in order to boost international shipments, the sector requires more government incentives and improved ease of doing...
The pharmaceutical sector is projected to reach $70.3 billion, with a 9 percent growth expected from FY25 to FY27, fueled by rising exports to nations such as the US, as well as by new products introduced by Indian pharmaceutical firms. It is...
In the upcoming five years, almost 70 percent of international pharmaceutical companies are predicted to experience yearly growth of over 10 percent in India. International pharmaceutical corporations have been essential in the change by bringing...
Dr Reddy's Laboratories announced the introduction of Toripalimab in India for treating recurrent or metastatic nasopharyngeal carcinoma. Nasopharyngeal carcinoma (NPC) is an uncommon, fast-growing type of head and neck cancer that starts in the...
, CDSCO.jpg)
